The 10/90 gap in sub-Saharan Africa: Resolving inequities in health research

Acta Tropica

Volumn 112, Issue SUPPL. 1, 2009, Pages

  Kilama, Wen L ^a  

^a African Malaria Network Trust   (Tanzania)

Author keywords

10 90 Gap; Capacity building; Health research; Sub Saharan Africa

Indexed keywords

ALBENDAZOLE; ARTEMISIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IVERMECTIN; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

CAPACITY BUILDING; EDUCATION; HEALTH POLICY; HEALTH SERVICES; NONGOVERNMENTAL ORGANIZATION; POVERTY; RESEARCH;

AFRICA; ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; EDUCATION; FINANCIAL MANAGEMENT; FUNDING; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJURY; MALARIA; MEDICAL RESEARCH; ONCHOCERCIASIS; POVERTY; PRODUCT DEVELOPMENT; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; TELECOMMUNICATION; VISCERAL LEISHMANIASIS;

ACADEMIES AND INSTITUTES; AFRICA SOUTH OF THE SAHARA; BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; FINANCING, GOVERNMENT; HUMANS;

AFRICA; SUB-SAHARAN AFRICA;

EID: 70349171114     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.08.015     Document Type: Article

References (22)

1. Abuja Declaration on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases (2009). http://www.un.org/ga/aids/pdf/abuja_declaration.pdf http://www.un.org/ga/aids/pdf/abuja_declaration.pdf (accessed 09.06.09).
2. Abuja Declaration on Roll Back Malaria in Africa (2000). http://www.rbm.who.int/docs/abuja_declaration.pdf http://www.rbm.who.int/docs/abuja_declaration.pdf (accessed 09.06.09).
3. Adams C., and Brantner V. Estimating the cost of new drug development: is it really 802 million dollars?. Health Affairs 25 2 (2006) 420-428
4. Bloom B.R., Catherine M.M., La Montagne J.R., and Simonsen L. Priorities for global research and development of interventions. In: Jamison D.T., Breman J.G., Measham A.R., et al. (Eds). Disease Control Priorities in Developing Countries. 2nd ed. (2006), Oxford University Press and The World Bank, Washington, DC pp. 103-118
5. In: Burke M.A., and de Francisco A. (Eds). Monitoring Financial Flows for Health Research (2004), Global Forum for Health Research, Geneva 105 pp.
6. In: Burke M.A., and Matlin S.A. (Eds). Monitoring Financial Flows for Health Research (2008), Global Forum for Health Research, Geneva 122 pp.
7. Commission on Health Research for Development Health Research: Essential Link to Equity in Development (1990), Oxford University Press, New York. http://www.cohred.org/ www.cohred.org
8. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects (2002), CIOMS, Geneva 112 pp.
9. DiMasi J., Hansen R., and Grabowski H. The price of innovation: new estimates of drug development costs. Health Econ. 22 2 (2003) 151-185
10. Doyal L. Gender and the 10/90 gap in health research. Bull. World Health Organizat. March (2008) 162
11. Frost L.J., and Reich M.R. Access: How Do Health Technologies Get to Poor People in Poor Countries? (2008), Harvard Center for Population and Development Studies, Cambridge, Mass
12. Gallup J.L., and Sachs J.D. The economic burden of malaria. Am. J. Trop. Med. Hygiene 64 (1,2) S (2001) 85-96
13. Hotez P.J., Molyneux D.H., Fenwick A., et al. Control of neglected tropical diseases. N. Eng. J. Med. 357 10 (2007) 1018-1027
14. International Conference on Harmonization of Good Clinical Practice (1996)
15. Kilama W.L., et al. Towards an African-driven malaria vaccine development program: history and activities of the African malaria network trust. Am. J. Trop. Med. Hygiene 77 6S (2007) 282-288
16. Matlin S. Focusing collaborative efforts on research and innovation for the health of the poor. Health Partnership Review: Focusing Collaborative Efforts on Research and Innovation for the Health of the Poor (2008), Global Forum for Health Research, Geneva
17. Mahmoud A., Danzon P.M., Barton J.H., and Mugerwa R.D. Product Development Priorities (2006)
18. Moran M., Guzman J., Ropars A.-L., et al. Neglected diseases research and development: how much are we really spending?. Plos Med. 6 2 (2009)
19. Nyika A., Kilama W., Chilengi R., Tangwa G., Tindana P., Ndebele P., and Ikingura J. Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?. J. Med. Ethics 35 (2009) 189-193. http://jme.bmj.com/cgi/content/abstract/35/3/189 Available at: http://jme.bmj.com/cgi/content/abstract/35/3/189
20. Reich M. The global drug gap. Science 287 (2000) 1979-1981
21. United Nations. World Population Prospects. The 2004 Revision (2005), United Nations, New York
22. World Health Organization. The Global Burden of Disease: 2004 update (2008), World Health Organization, Geneva